DNA microarrays in the clinic?;Des puces ADN en clinique?

Medecine/Sciences

Volumn 23, Issue 2, 2007, Pages 210-214

  Jordan, Bertrand ^a  

^a Parc Scientifique de Luminy   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; TRANSMEMBRANE CONDUCTANCE REGULATOR; CFTR PROTEIN, HUMAN; CYP2C19 PROTEIN, HUMAN; CYTOCHROME P450 2D6; MIXED FUNCTION OXIDASE; UNCLASSIFIED DRUG; UNSPECIFIC MONOOXYGENASE;

BREAST CANCER; CANCER LOCALIZATION; COMPARATIVE GENOMIC HYBRIDIZATION; DIAGNOSTIC PROCEDURE; DNA MICROARRAY; DYSTROPHY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE FREQUENCY; GENE NUMBER; GENETIC VARIABILITY; HEALTH CARE UTILIZATION; HEREDITY; HUMAN; PROTEIN EXPRESSION; REVIEW; BIOTRANSFORMATION; BREAST TUMOR; CYSTIC FIBROSIS; FAMILIAL CANCER; FEMALE; FORECASTING; GENE EXPRESSION PROFILING; GENETIC DISORDER; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETICS; HETEROZYGOTE DETECTION; MALE; METHODOLOGY; NUCLEIC ACID HYBRIDIZATION; PREDICTION AND FORECASTING; PROFESSIONAL PRACTICE; REPRODUCIBILITY; UTILIZATION REVIEW;

ARYL HYDROCARBON HYDROXYLASES; BIOTRANSFORMATION; BREAST NEOPLASMS; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; CYTOCHROME P-450 CYP2D6; FEMALE; FORECASTING; GENE EXPRESSION PROFILING; GENETIC DISEASES, INBORN; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HETEROZYGOTE DETECTION; HUMANS; MALE; MIXED FUNCTION OXYGENASES; NEOPLASTIC SYNDROMES, HEREDITARY; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROFESSIONAL PRACTICE; REPRODUCIBILITY OF RESULTS; VARIATION (GENETICS);

EID: 33847116537     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.1051/medsci/2007232210     Document Type: Review

References (12)

1. Shi L, Reid LH, Jones WD, et al. The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nat Biotechnol 2006 ; 24 : 1151-61.
2. Redon R, Ishikawa S, Fitch KR, et al. Global variation in copy number in the human genome. Nature 2006 ; 444 : 444-54.
3. Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000 ; 403 : 503-11.
4. Bertucci F, Houlgatte R, Benziane A, et al. Gene expression profiling of primary breast carcinomas using arrays of candidate genes. Hum Mol Genet 2000 ; 9 : 2981-91.
5. Jardin F, Tilly H. Un saut (de puce) vers une application clinique des profils d'expression génique dans les lymphomes ? Med Sci (Paris) 2004 ; 20 : 848-50.
6. Jordan B. Coup de tabac sur les puces. Med Sci (Paris) 2004 ; 20 : 487-90.
7. Paik S, Kim CY, Song YK, Kim WS. Technology insight: application of molecular techniques to formalin-fixed paraffin-embedded tissues from breast cancer. Nat Clin Pract Oncol 2005 ; 5 : 246-54.
8. Paik S, Shak S, Tang G, et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 2004 ; 351 : 2817-26.
9. Van't Veer LJ, Dai H, van de Vijver MJ, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002 ; 415 : 530-6.
10. Van de Vijver MJ, He YD, van't Veer LJ, et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 2002 ; 347 : 1999-2009.
11. Bertucci F, Nasser V, Granjeaud S, et al. Gene expression profiles of poor-prognosis primary breast cancer correlate with survival. Hum Mol Genet 2002 ; 11 : 863-72.
12. Bertucci F, Finetti P, Rougemont J, et al. Gene expression profiling for molecular characterization of inflammatory breast cancer and prediction of response to chemotherapy. Cancer Res 2004 ; 64 : 8558-65.